Evolutionary Genomics, Inc. filed its 10-K on Mar 09, 2023 for the period ending Dec 31, 2022. In this report its auditor, Plante & Moran, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% | -.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.99M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- FNAM Stock
- News Evolutionary Genomics, Inc.
- Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt